On the same line, MoDCs from CAPS patients exhibited enhanced secretion of IL-1β and IL-23 upon TLRs stimulation, with a reduction after anti-IL-1 treatment. This evidence concerns the gene IL1B and cryopyrin-associated periodic syndrome.